|
시장보고서
상품코드
2054877
울혈성심부전 시장(유형별)Congestive Heart Failure Market, By Type (Systolic Heart Failure, Diastolic Heart Failure, Acute Heart Failure, and Chronic Heart Failure, By Diagnosis, By Device Type, By Gender, By Age Group, By End User, By Geography ) |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
울혈성심부전 시장은 2026년에 268억 달러로 추정되고 있으며, 2033년까지 445억 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 7.5%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 268억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 7.50% | 2033년 시장 규모 예측 : | 445억 달러 |
전 세계 울혈성심부전 시장은 심혈관 질환 유병률 증가, 고령 인구 증가, 그리고 효과적인 치료법에 대한 수요 증가를 배경으로 최근 수년간 인상적인 성장을 달성하고 있습니다. 울혈성심부전(CHF)은 심장이 신체의 필요량을 충족시킬 만큼 충분한 혈액을 펌프질하지 못하는 것이 특징인 만성질환입니다. 첨단 진단 기술과 혁신적인 치료법의 등장으로 CHF 관리 시장은 크게 확대되고 있습니다.
시장 역학:
전 세계 울혈성심부전 시장은 심혈관 질환 유병률의 증가, 고령 인구 증가, 앉아 있는 생활 습관의 확산 등 여러 요인에 의해 성장하고 있습니다. 또한 CHF의 조기 진단과 치료의 중요성에 대한 인식이 높아지고 있는 점도 시장 성장에 기여하고 있습니다. 그러나 높은 치료비와 일부 지역의 보험 환급 제도 미비 사항이 시장 성장을 저해할 가능성이 있습니다. 또한 일부 치료법에 수반되는 부작용 역시 시장 성장을 저해할 가능성이 있습니다. 한편, 유전자 치료나 줄기세포 치료와 같은 새로운 치료법의 개발과 맞춤형 의료에 대한 관심 증가는 시장 관계자들에게 큰 성장 기회를 제공하고 있습니다. 새로운 치료법 개발을 위한 제약사와 연구 기관 간의 협력 강화 역시 향후 수년간 시장 성장을 촉진할 것으로 예상됩니다.
본 조사의 주요 특징:
- 본 조사에서는 각 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 업체들이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 울혈성심부전 시장의 주요 기업 개요을 작성했습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 이 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 이 보고서는 전 세계 울혈성심부전 시장을 다루며, 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 해당 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 울혈성심부전 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 울혈성심부전 시장 : 유형별, 2021-2033년
제5장 세계의 울혈성심부전 시장 : 진단별, 2021-2033년
제6장 세계의 울혈성심부전 시장 : 디바이스 유형별, 2021-2033년
제7장 세계의 울혈성심부전 시장 : 성별, 2021-2033년
제8장 세계의 울혈성심부전 시장 : 연령층별, 2021-2033년
제9장 세계의 울혈성심부전 시장 : 최종사용자별, 2021-2033년
제10장 세계의 울혈성심부전 시장 : 지역별, 2021-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌 및 조사 방법
KSA 26.06.18Congestive Heart Failure Market is estimated to be valued at USD 26.80 Bn in 2026 and is expected to reach USD 44.50 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 26.80 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.50% | 2033 Value Projection: | USD 44.50 Bn |
The global congestive heart failure market has witnessed significant growth in recent years, driven by the increasing prevalence of cardiovascular diseases, the rising geriatric population, and the growing demand for effective treatment options. Congestive heart failure (CHF) is a chronic condition characterized by the heart's inability to pump sufficient blood to meet the body's needs. With the advent of advanced diagnostic techniques and innovative treatment approaches, the market for CHF management has expanded considerably.
Market Dynamic:
The global congestive heart failure market is driven by several factors, including the rising prevalence of cardiovascular diseases, the growing geriatric population, and the increasing adoption of sedentary lifestyles. The increasing awareness about the importance of early diagnosis and treatment of CHF have also contributed to the market growth. However, the high cost of treatment and the lack of reimbursement policies in some regions may restrain the market growth. Moreover, the side effects associated with some of the available treatment options may also hinder the market growth. On the other hand, the development of novel therapies, such as gene therapy and stem cell therapy, and the increasing focus on personalized medicine offer significant growth opportunities for the market players. Increasing collaborations between pharmaceutical companies and research institutes for the development of novel therapies are also expected to drive the market growth in the coming years.
Key Features of the Study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global congestive heart failure market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Novartis, Boehringer Ingelheim, AstraZeneca, Johnson & Johnson, Abbott, Medtronic, Boston Scientific, Pfizer, Merck & Co, Bristol Myers Squibb, LivaNova, Biotronik, V-Wave, Impulse Dynamics, and CVRx
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global congestive heart failure market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global congestive heart failure market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Systolic Heart Failure
- Diastolic Heart Failure
- Acute Heart Failure
- Chronic Heart Failure
- Diagnosis Insights (Revenue, USD Bn, 2021 - 2033)
- Echocardiography
- Chest X-Ray
- Blood Tests (BNP, NT-proBNP)
- Cardiac Catheterization
- Magnetic Resonance Imaging
- Holter Monitoring
- Nuclear Imaging
- Device Type Insights (Revenue, USD Bn, 2021 - 2033)
- Pacemakers
- Implantable Cardioverter-Defibrillators (ICDs)
- Cardiac Resynchronization Therapy (CRT) Devices
- Ventricular Assist Devices (VADs)
- Remote Monitoring Devices
- Others
- Gender Insights (Revenue, USD Bn, 2021 - 2033)
- Male
- Female
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Adult
- Pediatrics
- Geriatric
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- Home Healthcare
- Academic and Research Institutes
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Novartis
- Boehringer Ingelheim
- AstraZeneca
- Johnson & Johnson
- Abbott
- Medtronic
- Boston Scientific
- Pfizer
- Merck & Co
- Bristol Myers Squibb
- LivaNova
- Biotronik
- V-Wave
- Impulse Dynamics
- CVRx
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Congestive Heart Failure Market, By Type
- Global Congestive Heart Failure Market, By Diagnosis
- Global Congestive Heart Failure Market, By Device Type
- Global Congestive Heart Failure Market, By Gender
- Global Congestive Heart Failure Market, By Age Group
- Global Congestive Heart Failure Market, By End User
- Global Congestive Heart Failure Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Congestive Heart Failure Market, By Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Systolic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diastolic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Acute Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chronic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Congestive Heart Failure Market, By Diagnosis, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Echocardiography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chest X-Ray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Blood Tests (BNP, NT-proBNP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiac Catheterization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Magnetic Resonance Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Holter Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nuclear Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Congestive Heart Failure Market, By Device Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pacemakers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Implantable Cardioverter-Defibrillators (ICDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiac Resynchronization Therapy (CRT) Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ventricular Assist Devices (VADs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Remote Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Congestive Heart Failure Market, By Gender, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Congestive Heart Failure Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Congestive Heart Failure Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Healthcare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Congestive Heart Failure Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LivaNova
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biotronik
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- V-Wave
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Impulse Dynamics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CVRx
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
